Non-Abbott Product
Device
Abbott Laboratories
Total Payments
$491,876
Transactions
26
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $491,876 | 26 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $491,876 | 26 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy of DE-MRI-Guided Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation (DECAAF II) | Abbott Laboratories | $408,960 | 0 |
| Effect of Acetaminophen on the Accuracy of the Dexcom G6 Continuous Glucose Monitoring System | Abbott Laboratories | $74,522 | 0 |
Top Doctors Receiving Payments for Non-Abbott Product
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Gaithersburg, MD | $491,876 | 26 |
Ad
Manufacturing Companies
- Abbott Laboratories $491,876
Product Information
- Type Device
- Total Payments $491,876
- Total Doctors 0
- Transactions 26
About Non-Abbott Product
Non-Abbott Product is a device associated with $491,876 in payments to 0 healthcare providers, recorded across 26 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $491,876 was paid across 26 transactions to 0 doctors.
The most common payment nature for Non-Abbott Product is "Unspecified" ($491,876, 100.0% of total).
Non-Abbott Product is associated with 2 research studies, including "Efficacy of DE-MRI-Guided Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation (DECAAF II)" ($408,960).